ClinicalTrials.gg
RecruitingNCT06737627Updated Apr 24, 2026

Development and Validation of the Observatory Battery of Common Eye Disorders for Adults With Intellectual Disability

An observational study in Intellectual Disability, sponsored by National Taiwan University Hospital. Recruiting at 2 sites in Taiwan. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by National Taiwan University Hospital · Observational

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,400
Ages
20 Years and older
Sex
All
01

Study summary

Background:

Around 15% of the global population has some form of disability. Rights to obtain proper health care is an emphasis in the United Nationals Convention on the Right of People with Disability. Due to the importance of improving vision health for people with disabilities, studies on how to identify vision problems becomes extremely important in policy formulation for all countries. Among all types of disabilities, people with intellectual disability (ID) are among the ones where vision problems are the hardest to detect.

Currently, no caregiver assessable scales are available, as a result, adults with ID are at high risk of delayed diagnose for common ocular conditions. Objectives: This is a one-year project.

The objective of this study is two folds:

  1. To develop an item bank of ocular conditions of adults with ID;
  2. To develop a scale for caregivers to detect ocular conditions for adults with ID, and to validate the reliability, construct validity and responsiveness of the scale.
02

Conditions studied

  • Intellectual Disability

Keywords

  • Intellectual disability, Adults, Visual Scale, Caregiver
03

In context

Intellectual Disability

387 studies on the registry are indexed under Intellectual Disability; 105 are open to participants now.

This study's planned enrollment of 1,400 is above the median of 150 across 125 observational studies indexed under Intellectual Disability.

Browse Intellectual Disability studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,615 studies on the registry; 576 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Intellectual disability

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 20 and above
  2. Primary caregivers for at least one adult with ID (have disability identification or (and) certification).

Exclusion criteria

Exclusion Criteria:

  1. Unable to communicate in Mandarin or Taiwanese.(Primarycaregivers)
  2. Unable to cooperate with eye examination.(ID)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intellectual disability

    Other: no intervention

Interventions

  • Otherno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Collection of Socioeconomic Data for Individuals with Disabilities

    This study collects basic socioeconomic data of individuals with disabilities through tailored questionnaires, including gender, date of birth, educational background, living conditions, and employment status. The questionnaire is designed to accommodate the specific characteristics of individuals with intellectual disabilities and is completed by respondents or their proxies. These data will be analyzed to understand the impact of socioeconomic factors on the visual health and accessibility to medical services for people with disabilities. Ethical guidelines are strictly followed to ensure confidentiality and protect participant rights.

    Time frame: 1-3 months

  2. Assessment Scales for Individuals with Disabilities

    This study utilizes validated assessment tools to evaluate the visual functions and daily living abilities of individuals with disabilities. These include the Activities of Daily Living (ADL) Scale and Instrumental Activities of Daily Living (IADL) Scale, supplemented by specific observational items for visual health and related functional behaviors. The scales employ a graded scoring system covering personal hygiene, mobility, social interaction, and visual challenges. The collected data will help analyze the impact of visual impairment on independent living skills and support the development of tailored visual intervention strategies. Participant privacy and ethical compliance are rigorously maintained.

    Time frame: 1-3 months

  3. Ophthalmologic Examination Form

    A standardized ophthalmologic examination form is employed in this study to record detailed visual and eye health data of individuals with disabilities. The form includes uncorrected and corrected visual acuity, intraocular pressure, eye movement, corneal conditions, iris, macula, retina, and other ocular components. It also documents spherical power, cylindrical power, and axis to assess refractive correction needs. The form provides a section for medical recommendations such as eyeglass prescription, medical referral, or regular follow-up. These comprehensive data support analysis of visual problems' effects on individuals and guide the formulation of personalized visual intervention plans.

    Time frame: 1-3 months

07

Study locations

2 of 2 sites recruiting
  • Care facility
    New Taipei City, Taiwan
    Recruiting
  • Care facility
    Taipei, Taiwan
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jan 2027, 33 months after the start.

Of 47 non-industry observational studies under Intellectual Disability, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 203. This study's planned 33 months is below that.

Counting every sponsor, half of 48 studies reached it within 59 months; a quarter within 19 and three quarters within 203.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2024
First posted
Dec 17, 2024
StartActual
Apr 9, 2024
Primary completionEst.
Jan 29, 2027
CompletionEst.
Dec 31, 2027
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06737627
Responsible party
Sponsor
First posted
Dec 17, 2024
Start date
Apr 9, 2024
Primary completion
Jan 29, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 24, 2026

Study contacts

Chiun-Ho Hou, Ph.D
Contact
chiunhohou@gmail.com
+88623123456 ext. 262131

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion